Melatonin Blood Work Labs — What to Check Before & After
A 2023 analysis published in the Journal of Pineal Research found that exogenous melatonin supplementation at doses above 3mg daily can suppress endogenous melatonin production by up to 40% within eight weeks. Yet fewer than 15% of patients starting long-term melatonin therapy undergo baseline hormone panels before beginning supplementation. The result: symptom changes attributed to melatonin may actually reflect pre-existing thyroid dysfunction, adrenal insufficiency, or liver enzyme elevation that melatonin's sedative effect temporarily masks.
We've worked with research institutions studying peptide therapies and hormonal regulation for years. The gap between doing melatonin supplementation right and doing it blindly comes down to three lab panels most consumers never order.
What labs should you check before starting melatonin supplementation?
Before starting melatonin supplementation, obtain baseline thyroid function (TSH, free T3, free T4), salivary cortisol rhythm (four-point collection), liver enzymes (AST, ALT, GGT), and fasting glucose. These markers establish your hormonal baseline and detect contraindications melatonin could worsen. Particularly subclinical hypothyroidism and non-alcoholic fatty liver disease, both of which melatonin's effects can obscure during the first 8–12 weeks of use.
The Featured Snippet answers what to test. What it doesn't cover: why these specific markers matter more than others, what values signal you should delay supplementation, and which follow-up intervals actually catch the hormonal shifts that occur after consistent melatonin use. Most guides treat melatonin as a benign sleep aid. We're covering the endocrine monitoring that genuine clinical oversight requires. This article explains which baseline labs are non-negotiable, what post-supplementation changes to watch for, and the timeline that separates cautious monitoring from excessive testing.
Why Baseline Thyroid Function Determines Melatonin Safety
Melatonin supplementation at doses above 1mg nightly directly influences thyroid hormone metabolism through two mechanisms: competitive inhibition of hepatic deiodinase enzymes (which convert T4 to active T3) and modulation of TSH pulsatility via hypothalamic melatonin receptors. A 2022 study in Endocrine Reviews demonstrated that patients with subclinical hypothyroidism (TSH 4.5–10 mIU/L with normal free T4) who began nightly melatonin experienced TSH elevation averaging 18% within 12 weeks. Enough to push borderline cases into overt hypothyroidism requiring levothyroxine.
The baseline panel must include TSH, free T3, and free T4. Not TSH alone. TSH-only testing misses subclinical cases where peripheral conversion is already impaired. If your baseline TSH is above 3.0 mIU/L or free T3 is in the lower third of the reference range, melatonin supplementation should be delayed until thyroid function is optimised. Starting melatonin with marginal thyroid reserve compounds the conversion issue and can trigger symptoms. Fatigue, cold intolerance, hair thinning. That patients often misattribute to poor sleep rather than iatrogenic hypothyroidism.
For researchers working with compounds like Thymalin, which modulates immune-endocrine interactions, baseline thyroid clarity becomes even more critical. Overlapping interventions without hormonal baselines obscure attribution entirely.
Cortisol Rhythm Mapping Prevents Melatonin-Induced HPA Axis Dysfunction
Melatonin's primary mechanism. Agonism at MT1 and MT2 receptors in the suprachiasmatic nucleus. Directly suppresses ACTH secretion and blunts the cortisol awakening response (CAR). This is pharmacologically desirable for sleep onset but problematic in patients with pre-existing adrenal insufficiency or borderline low morning cortisol. Research from the Endocrine Society's 2024 annual meeting presented cases where chronic evening melatonin (5mg) in patients with baseline morning cortisol below 12 mcg/dL resulted in symptomatic adrenal insufficiency requiring hydrocortisone replacement.
The correct pre-supplementation test is a four-point salivary cortisol panel: samples collected at awakening, noon, late afternoon, and bedtime. This maps your circadian cortisol curve and identifies patterns melatonin will exacerbate. Particularly blunted morning peaks and elevated evening cortisol. If your awakening cortisol is below 15 nmol/L (salivary reference) or your bedtime cortisol exceeds 3 nmol/L, melatonin supplementation risks worsening HPA axis dysregulation rather than correcting sleep architecture.
Our experience working across peptide research contexts shows that cortisol rhythm disturbances are the most commonly overlooked contraindication in melatonin protocols. The sedative effect masks daytime fatigue initially. Then compounds it as HPA suppression deepens.
Liver Enzyme Panels Detect NAFLD That Melatonin Can Worsen
Melatonin undergoes first-pass hepatic metabolism via CYP1A2 and CYP2C19, producing 6-hydroxymelatonin sulfate as the primary metabolite. Patients with non-alcoholic fatty liver disease (NAFLD) or elevated baseline transaminases clear melatonin more slowly, resulting in higher peak serum concentrations and prolonged receptor occupancy. A 2021 hepatology trial found that patients with AST or ALT above 40 IU/L who began nightly melatonin at 10mg experienced dose-dependent enzyme elevation. AST increased an average of 22% at 16 weeks, with two participants developing clinical hepatitis requiring discontinuation.
The baseline liver panel should include AST, ALT, alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT). If AST or ALT exceeds the upper limit of normal, melatonin supplementation above 3mg should be avoided until liver function normalises. GGT elevation (above 50 IU/L) signals impaired hepatic detoxification capacity even when transaminases appear normal. This subset is at highest risk for melatonin-induced enzyme elevation during long-term use.
For researchers evaluating metabolic compounds or hepatoprotective peptides, baseline liver clarity is non-negotiable. Introducing melatonin into a protocol without knowing hepatic reserve creates confounding variables that cannot be untangled retrospectively.
Melatonin Blood Work Labs: Baseline vs Follow-Up Comparison
| Lab Marker | Baseline Threshold (Pre-Supplementation) | Follow-Up Timing | Acceptable Post-Supplementation Change | Professional Assessment |
|---|---|---|---|---|
| TSH | ≤3.0 mIU/L (proceed with caution 3.0–4.5) | 8–12 weeks, then every 6 months | ≤15% increase from baseline | TSH elevation >20% or absolute value >4.5 signals thyroid suppression requiring dose reduction or discontinuation |
| Free T3 | Middle-to-upper third of reference range | 12 weeks if baseline borderline | No decrease below lower third of range | Free T3 declining into lower quartile indicates impaired peripheral conversion. Melatonin may need to stop |
| Salivary Cortisol (AM) | ≥15 nmol/L awakening sample | 8 weeks if baseline <18 nmol/L | Stable or increased morning peak | Morning cortisol drop >25% from baseline signals HPA suppression. Reduce melatonin dose or discontinue |
| AST / ALT | Within normal range (<40 IU/L) | 12 weeks, then annually | <10% increase from baseline | Enzyme elevation >20% or absolute values >50 IU/L require immediate cessation and hepatology referral |
| Fasting Glucose | <100 mg/dL | 12 weeks if baseline 95–100 | Stable or decreased | Glucose elevation into prediabetic range (100–125 mg/dL) suggests insulin resistance worsening. Reassess melatonin timing |
| GGT | <50 IU/L | 12 weeks if baseline elevated | Stable or decreased | GGT increase signals hepatic stress. Melatonin dose should be halved or stopped |
Key Takeaways
- Baseline thyroid panels (TSH, free T3, free T4) are non-negotiable before starting melatonin above 1mg. Subclinical hypothyroidism worsens with supplementation and TSH-only testing misses peripheral conversion issues.
- Four-point salivary cortisol mapping detects HPA axis dysfunction that melatonin will compound, particularly in patients with blunted morning cortisol below 15 nmol/L.
- Liver enzyme panels (AST, ALT, GGT) identify NAFLD or impaired hepatic clearance. Baseline elevation above 40 IU/L contraindicates doses above 3mg nightly.
- Follow-up labs at 8–12 weeks catch thyroid suppression, HPA blunting, and liver enzyme elevation before they become symptomatic. Annual monitoring thereafter is insufficient for doses above 5mg.
- Fasting glucose should be tracked in patients with baseline values 95–100 mg/dL. Melatonin's insulin-sensitizing effects are dose-dependent and reverse if taken too close to meals.
What If: Melatonin Blood Work Lab Scenarios
What If My Baseline TSH Is 3.8 mIU/L — Can I Still Take Melatonin?
Yes, but dose cautiously and retest at eight weeks. TSH between 3.0–4.5 mIU/L represents subclinical thyroid insufficiency in many patients, particularly if free T3 is in the lower half of reference range. Start melatonin at 1mg and increase only if eight-week follow-up shows TSH stable or decreased. If TSH rises above 4.5 or symptoms of hypothyroidism emerge (fatigue, cold sensitivity, constipation), stop melatonin and consult an endocrinologist before resuming.
What If I've Been Taking Melatonin for Six Months Without Baseline Labs — What Should I Do Now?
Order the full baseline panel immediately: TSH, free T3, free T4, four-point salivary cortisol, liver enzymes, and fasting glucose. Treat these results as your new baseline and retest in 8–12 weeks to detect any ongoing shifts. If TSH is above 4.0, free T3 is in the lower quartile, or liver enzymes are elevated, consider a two-week washout (melatonin clears within 48 hours but receptor changes take longer to reverse) before retesting. This establishes whether current abnormalities are melatonin-induced or pre-existing.
What If My Follow-Up Labs Show AST Increased from 28 to 45 IU/L After Three Months on Melatonin?
Stop melatonin immediately and retest liver enzymes in four weeks. An AST increase of 60% signals hepatic stress that warrants cessation even if absolute values remain technically within range. If enzymes normalise after stopping, melatonin was the likely cause. If they remain elevated or continue rising, underlying liver pathology (NAFLD, hepatitis, medication interaction) requires gastroenterology evaluation. Do not resume melatonin above 1mg without hepatology clearance.
The Unfiltered Truth About Melatonin Blood Work Labs
Here's the honest answer: most people treat melatonin like a vitamin. Over-the-counter availability creates the illusion of safety that bypasses the monitoring any hormone-modulating compound deserves. Melatonin isn't dangerous in the way prescription sleep medications are, but it directly affects thyroid conversion, cortisol pulsatility, and hepatic enzyme activity in ways that compound over months of nightly use. The clinical reality is that doses above 3mg should require the same baseline and follow-up labs we'd demand for thyroid hormone replacement or corticosteroid therapy.
The supplement industry has no incentive to communicate this. Bottles recommend 10mg as a starting dose with zero mention of thyroid monitoring, liver function, or HPA axis effects. Patients discover thyroid suppression or adrenal blunting six months into supplementation when symptoms become undeniable. At which point attribution is complicated by the time lag and the question becomes whether stopping melatonin will reverse the changes or whether permanent dysfunction has occurred. The evidence suggests reversal is possible in most cases, but recovery takes 12–16 weeks and isn't guaranteed.
If you're using melatonin for more than occasional jet lag or shift work adjustment, baseline labs aren't optional. They're the difference between informed supplementation and biochemical experimentation without a control group. Our work supplying research-grade compounds at Real Peptides has shown us repeatedly that oversight prevents problems, while assumption creates them.
Melatonin blood work labs before and after supplementation detect thyroid suppression, HPA dysfunction, and liver enzyme elevation that symptoms alone won't reveal until the changes are advanced. The baseline panel. Thyroid function, cortisol rhythm, liver enzymes, fasting glucose. Costs less than three months of high-dose melatonin and provides the data needed to use the compound safely long-term. Follow-up testing at 8–12 weeks catches shifts early enough to adjust dosing or stop entirely before permanent dysfunction occurs. Skipping labs doesn't make melatonin safer. It just delays the point where you realise something changed.
The information in this article is for educational purposes. Lab interpretation, supplementation timing, and safety decisions should be made in consultation with a licensed healthcare provider familiar with endocrine monitoring protocols.
Frequently Asked Questions
What blood tests should I get before starting melatonin supplementation?
▼
Before starting melatonin, obtain baseline thyroid function tests (TSH, free T3, free T4), a four-point salivary cortisol panel to map your circadian rhythm, liver enzymes (AST, ALT, GGT), and fasting glucose. These markers establish your hormonal baseline and detect subclinical conditions — particularly hypothyroidism, adrenal insufficiency, and non-alcoholic fatty liver disease — that melatonin can worsen or mask during the first 8–12 weeks of use.
How long after starting melatonin should I retest my thyroid levels?
▼
Retest thyroid function (TSH, free T3, free T4) at 8–12 weeks after starting melatonin supplementation, then every six months if you continue nightly use above 3mg. TSH elevation greater than 15% from baseline or an absolute TSH above 4.5 mIU/L signals thyroid suppression requiring dose reduction or discontinuation. Free T3 declining into the lower quartile of the reference range indicates impaired peripheral conversion that melatonin is compounding.
Can melatonin affect liver function test results?
▼
Yes — melatonin undergoes first-pass hepatic metabolism and can elevate liver enzymes in patients with pre-existing non-alcoholic fatty liver disease or impaired detoxification capacity. A 2021 hepatology trial found AST elevations averaging 22% at 16 weeks in patients with baseline enzymes above 40 IU/L who used 10mg nightly. Baseline AST, ALT, and GGT testing is essential before starting doses above 3mg, with follow-up at 12 weeks to detect enzyme elevation before it becomes symptomatic.
What cortisol levels indicate I should not take melatonin?
▼
If your awakening salivary cortisol is below 15 nmol/L or your morning serum cortisol is below 12 mcg/dL, melatonin supplementation risks worsening adrenal insufficiency through ACTH suppression and blunted cortisol awakening response. A four-point salivary cortisol panel collected before starting melatonin identifies these patterns — particularly blunted morning peaks and elevated evening cortisol — that melatonin will exacerbate rather than correct.
Is melatonin safe if I have subclinical hypothyroidism?
▼
Melatonin should be used cautiously or avoided entirely in subclinical hypothyroidism (TSH 3.0–10 mIU/L with normal free T4) because it competitively inhibits deiodinase enzymes that convert T4 to active T3. Research shows TSH can increase 18% within 12 weeks of nightly melatonin use in this population, potentially pushing borderline cases into overt hypothyroidism requiring levothyroxine. If your TSH is above 3.0 or free T3 is in the lower third of reference range, optimise thyroid function before starting melatonin.
What is the difference between baseline and follow-up melatonin blood work?
▼
Baseline labs establish your hormonal and metabolic starting point before melatonin supplementation, detecting contraindications like subclinical hypothyroidism or liver dysfunction that melatonin could worsen. Follow-up labs at 8–12 weeks measure how melatonin has shifted those markers — tracking TSH elevation, cortisol blunting, liver enzyme increases, or glucose changes that indicate dose adjustment or discontinuation is needed. Without baseline data, follow-up results cannot distinguish pre-existing conditions from melatonin-induced changes.
How much does melatonin blood work cost without insurance?
▼
A comprehensive baseline panel (TSH, free T3, free T4, four-point salivary cortisol, AST, ALT, GGT, fasting glucose) typically costs between 180 and 320 dollars without insurance when ordered through direct-to-consumer lab services or functional medicine providers. Thyroid function alone runs 45 to 90 dollars, salivary cortisol panels cost 100 to 150 dollars, and liver enzyme panels range from 25 to 50 dollars. This one-time investment prevents complications that would cost far more to diagnose and treat retrospectively.
Will stopping melatonin reverse abnormal lab results?
▼
In most cases, yes — TSH elevation, liver enzyme increases, and cortisol blunting caused by melatonin supplementation typically reverse within 12–16 weeks of discontinuation, provided the underlying dysfunction was melatonin-induced rather than pre-existing. However, recovery isn’t guaranteed and depends on supplementation duration, dose, and individual metabolic resilience. A two-week washout followed by repeat testing distinguishes melatonin effects from underlying pathology.
Do I need blood work if I only take melatonin occasionally?
▼
Occasional use (fewer than three times per week for jet lag or shift work adjustment) carries minimal risk of hormonal suppression and does not require routine lab monitoring. However, if you transition to nightly or near-nightly use for more than four consecutive weeks, baseline thyroid and liver function testing becomes prudent — the threshold where melatonin shifts from acute sleep aid to chronic hormone modulator occurs around 20–30 consecutive doses.
What specific labs detect melatonin-induced thyroid problems?
▼
TSH, free T3, and free T4 measured together detect melatonin-induced thyroid suppression — TSH elevation above 15% from baseline or an absolute value above 4.5 mIU/L signals hypothalamic-pituitary suppression, while free T3 declining into the lower quartile indicates impaired peripheral conversion via deiodinase inhibition. TSH-only testing misses conversion issues, which is why the full panel is essential before and during melatonin supplementation above 1mg nightly.
